Pharmaceutical Medicine

Scope & Guideline

Unveiling groundbreaking findings in medication efficacy.

Introduction

Immerse yourself in the scholarly insights of Pharmaceutical Medicine with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1178-2595
PublisherSPRINGER INT PUBL AG
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2000 to 2001, from 2008 to 2024
AbbreviationPHARM MED / Pharm. Med.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGEWERBESTRASSE 11, CHAM CH-6330, SWITZERLAND

Aims and Scopes

The journal 'Pharmaceutical Medicine' focuses on advancing knowledge and practices in the pharmaceutical industry, particularly in the areas of drug development, regulatory affairs, and medical affairs. Its core aims and scopes include:
  1. Pharmaceutical Research and Development:
    Exploration of methodologies and innovations in drug discovery, development, and approval processes, with a focus on enhancing efficiency and effectiveness.
  2. Regulatory Affairs and Compliance:
    Analysis of regulatory frameworks, compliance challenges, and evolving guidelines affecting drug approval and market access across various regions.
  3. Medical Affairs and Education:
    Investigation into the role of medical affairs in the pharmaceutical industry, including education strategies for healthcare providers and engagement with patients.
  4. Pharmacovigilance and Drug Safety:
    Emphasis on monitoring drug safety post-marketing, signal detection, and implementation of risk minimization measures to ensure patient safety.
  5. Patient-Centric Approaches:
    Incorporation of patient perspectives in drug development and clinical trials, focusing on adherence, preferences, and outcomes.
  6. Emerging Technologies in Pharmaceuticals:
    Assessment of the impact of digital technologies, artificial intelligence, and real-world evidence on pharmaceutical practices and healthcare delivery.
Recent publications in 'Pharmaceutical Medicine' have highlighted several emerging themes that reflect the current trends and priorities in the pharmaceutical landscape. These areas are gaining attention and are likely to shape future research directions. The following points outline these trending and emerging scopes:
  1. Artificial Intelligence and Machine Learning Applications:
    The increasing integration of AI and machine learning in drug development and pharmacovigilance indicates a significant trend towards leveraging technology to enhance efficiency and data analysis.
  2. Patient-Centric Drug Development:
    A growing emphasis on patient engagement and the incorporation of patient preferences in clinical trial design and drug development processes showcases a shift towards more patient-centered approaches.
  3. Real-World Evidence Utilization:
    The use of real-world data to inform decision-making in drug approval and post-marketing assessments is emerging as a critical area of focus, reflecting the industry's need for better understanding of drug effectiveness in diverse populations.
  4. Diversity, Equity, and Inclusion in Clinical Trials:
    Increasing attention to diversity and inclusion within clinical trial populations highlights the industry's commitment to addressing health disparities and ensuring equitable access to treatments.
  5. Decentralized Clinical Trials:
    The rise of decentralized clinical trials, facilitated by technology and remote monitoring, represents a significant shift in how clinical studies are conducted, aiming to improve patient participation and data collection.

Declining or Waning

While 'Pharmaceutical Medicine' has consistently focused on various critical aspects of pharmaceutical science, certain themes have shown a decline in prominence over recent years. These waning scopes may reflect shifting priorities within the field or the maturation of certain topics. The following points summarize these declining themes:
  1. Traditional Clinical Trial Models:
    There is a noticeable decrease in publications focusing on conventional clinical trial methodologies, possibly due to the rise of decentralized trials and adaptive designs.
  2. Single-Use Drug Formulations:
    Research on single-use formulations seems to be declining as the industry shifts towards more comprehensive therapeutic strategies and complex drug delivery systems.
  3. Pharmaceutical Marketing Strategies:
    Discussions around traditional pharmaceutical marketing tactics are less frequent, indicating a shift towards more integrated and value-based approaches to market access.
  4. Regulatory Challenges in Established Markets:
    The focus on regulatory challenges specific to established markets (e.g., EU, USA) is diminishing, possibly as the industry adapts to newer regulatory frameworks and harmonization efforts.
  5. Post-Marketing Studies:
    There appears to be a reduction in studies solely dedicated to post-marketing surveillance of drugs, as new methodologies for real-world evidence gain traction.

Similar Journals

Iranian Journal of Pharmaceutical Research

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: BRIEFLANDISSN: 1735-0328Frequency: 4 issues/year

Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.

Pharmaceutical Patent Analyst

Transforming Pharmaceutical Research with Patent Expertise
Publisher: TAYLOR & FRANCIS LTDISSN: 2046-8954Frequency: 6 issues/year

Pharmaceutical Patent Analyst, published by Taylor & Francis Ltd, is a premier journal dedicated to the evolving fields of pharmaceutical science and patent law. Established in 2012, this journal provides a rigorous platform for scholarly articles, analytical studies, and insightful reviews that delve into the intersection of drug discovery, pharmaceutical innovation, and intellectual property rights. With a Q2 category ranking in Pharmaceutical Science and Q3 rankings in both Drug Discovery and Medicine (miscellaneous), it is recognized for its impactful contributions to the academic community and industry professionals alike. The journal aims to enhance the understanding of patent strategies, explore emerging pharmaceutical technologies, and foster dialogue on regulatory challenges, ultimately facilitating innovation in drug development. Although it does not currently offer open access, its comprehensive and high-quality content remains essential for researchers, professionals, and students pursuing excellence in pharmaceutical research and patent analysis.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Fostering breakthroughs in drug development and application.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Fostering collaboration in critical pharmaceutical research.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.

SAUDI PHARMACEUTICAL JOURNAL

Advancing pharmaceutical knowledge for a healthier tomorrow.
Publisher: ELSEVIERISSN: 1319-0164Frequency: 8 issues/year

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

International Journal of Pharmaceutical Investigation

Exploring Breakthroughs in Pharmaceutical Research
Publisher: INPHARM ASSOC, PHCOG NETISSN: 2230-973XFrequency: 4 issues/year

International Journal of Pharmaceutical Investigation, published by INPHARM ASSOC, PHCOG NET, is a premier platform dedicated to advancing the field of pharmaceutical sciences. With the ISSN 2230-973X and E-ISSN 2230-9713, this journal serves as a vital resource for researchers, professionals, and students focused on drug development, formulation, and efficacy. By fostering a rich discourse on innovative pharmaceutical practices and research breakthroughs, the journal plays a critical role in enhancing global health outcomes through groundbreaking scholarly work. The absence of open access allows for selective dissemination of high-quality content, promoting rigorous peer-review processes that uphold academic integrity. Featuring articles that span a diverse range of topics within pharmaceutical sciences, the International Journal of Pharmaceutical Investigation is committed to supporting the ongoing evolution of this dynamic field, making it an essential read for anyone engaged in pharmaceutical research and development.

Journal of Pharmaceutical Policy and Practice

Bridging the gap between research and pharmaceutical practice.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

FARMACIA

Championing Excellence in Pharmacology and Pharmaceutics.
Publisher: SOC STIINTE FARMACEUTICE ROMANIAISSN: 0014-8237Frequency: 6 issues/year

FARMACIA is a renowned academic journal published by the SOC STIINTE FARMACEUTICE ROMANIA, specializing in the field of pharmacology, toxicology, and pharmaceutics. With a rich history dating back to its initial publication years of 1945 to 1946, and ongoing contributions since 2008, the journal has established itself as a significant platform for disseminating cutting-edge research in the pharmaceutical sciences. Indexed in Scopus, it holds a commendable Q2 ranking in the Pharmacology, Toxicology and Pharmaceutics category, reflecting its importance in the field. The journal aims to foster knowledge sharing and innovation among researchers, professionals, and students alike, making it an essential resource for advancing pharmaceutical research. Although it does not currently offer Open Access, the content is accessible to a broad academic audience, ensuring valuable insights into current trends and discoveries in pharmacotherapy and drug development. For those seeking a deeper understanding of the evolving landscape of pharmaceutical sciences, FARMACIA provides a critical lens through which to explore and engage with the latest scientific advancements.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Advancing Innovations in Pharmaceutical Biotechnology
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1389-2010Frequency: 15 issues/year

CURRENT PHARMACEUTICAL BIOTECHNOLOGY is a prestigious academic journal dedicated to advancing the field of pharmaceutical biotechnology by publishing high-quality research articles, reviews, and innovatory methodologies. Published by Bentham Science Publishers Ltd, this journal has established a strong reputation in its field, reflected in its 2023 Scopus rankings: it holds an impressive Q2 classification in Pharmaceutical Science and Q3 in Biotechnology, indicating its significant impact within these disciplines. With an ISSN of 1389-2010 and an E-ISSN of 1873-4316, CURRENT PHARMACEUTICAL BIOTECHNOLOGY provides a reliable platform for disseminating valuable research findings and fostering collaboration among researchers, professionals, and students alike. The journal covers a wide array of topics, from drug development and delivery systems to innovative biotechnological techniques, thus serving as an essential resource for anyone interested in the cross-section of pharmaceutical science and biotechnology. Researchers can access a diverse range of articles that explore both theoretical frameworks and practical applications, reflecting the ongoing evolution and challenges in this dynamic field.

Indian Journal of Pharmaceutical Education and Research

Bridging local insights with global pharmaceutical advancements.
Publisher: ASSOC PHARMACEUTICAL TEACHERS INDIAISSN: 0019-5464Frequency: 4 issues/year

Indian Journal of Pharmaceutical Education and Research, published by the Association of Pharmaceutical Teachers of India, is a pivotal platform for scholarly discussion in the field of pharmacology, toxicology, and pharmaceutics. ISSN 0019-5464, this esteemed journal aims to foster the exchange of innovative research, clinical advancements, and educational practices within the pharmaceutical sciences community. As a Q3-ranked journal in its category as of 2023, it reflects a commitment to upholding the standards of academic excellence and contributes significantly to the ongoing development of pharmaceutical education. The journal is a valuable resource for researchers, professionals, and students, with content spanning various key areas including drug formulation, safety, and the latest trends in pharmaceutical education. By providing open access to its research and reviews, the journal ensures that vital information is disseminated widely, promoting collaboration and learning among stakeholders in the pharmaceutical sector. Based in Bangalore, India, the journal has been instrumental in highlighting regional research while fostering a global dialogue in pharmaceutical sciences. As it continues its journey from 2008 to 2024, it remains dedicated to impacting the field through rigorous peer-reviewed content and engaging with contemporary challenges in healthcare and education.